Charu Aggarwal, MD, MPH
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Abramson Cancer Center
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 1-800-789-7366
Education:
MD
Lady Hardinge Medical College, New Delhi, India, 2002.
MPH (Health Care Organization and Policy)
University of Alabama at Birmingham, 2005.
MD
Lady Hardinge Medical College, New Delhi, India, 2002.
MPH (Health Care Organization and Policy)
University of Alabama at Birmingham, 2005.
Post-Graduate Training
Internship in Internal Medicine, State University of New York, 2005-2006.
Residency in Internal Medicine, State University of New York, 2006-2008.
Fellowship in Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2008-2011.
Chief Fellow, Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2010-2011.
Internship in Internal Medicine, State University of New York, 2005-2006.
Residency in Internal Medicine, State University of New York, 2006-2008.
Fellowship in Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2008-2011.
Chief Fellow, Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2010-2011.
Certifications
American Board of Internal Medicine: Internal Medicine, 2008.
American Board of Internal Medicine: Hematology , 2011.
American Board of Internal Medicine: Medical Oncology , 2011.
Permanent linkAmerican Board of Internal Medicine: Internal Medicine, 2008.
American Board of Internal Medicine: Hematology , 2011.
American Board of Internal Medicine: Medical Oncology , 2011.
Selected Publications
Lustgarten DS, Deshpande C, Aggarwal C, Wang LC, Saloura V, Vachani A, Wang LP, Litzky L, Feldman M, Creaney J, Nowak AK, Langer CJ, Inghilleri S, Stella G, Albelda SM : Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma Journal of Thoracic Oncology Volume 8 (4): 469–477, April 2013.Aggarwal C, Meropol N J, Punt C J, Iannotti N, Saidman B H, Sabbath K D, Gabrail N Y, Picus J, Morse M A, Mitchell E, Miller M C, Cohen S J: Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 24(2): 420-8, Feb 2013.
Aggarwal C, Ranganathan A, Lustgarten DS et al: Circulating Tumor Cells In Patients With Small Cell Lung Cancer: A Marker Of Disease Burden, Therapeutic Response, And Predictor Of Disease Relapse. Journal of Thoracic Oncology September 2012.
Brady A, McNeill JD, Judy B, Evans T, Cohen RB, Langer C, Vachani A AND Aggarwal C: Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer patients treated with first-line chemotherapy. Journal of Clinical Oncology Supplement June 2012.
Ranganathan A, Schwed-Lustgarten D, Aggarwal C et al: Circulating tumor cells in patients with small cell lung cancer: a marker of disease burden, therapeutic response, and predictor of disease relapse Journal of Clinical Oncology Supplement June 2012.
Aggarwal C, Somaiah N, Simon G. : Antiangiogenic agents in the management of non-small cell lung cancer: Where do we stand now and where are we headed? Cancer Biology and Therapy 13(5): 247-63, March 2012.
Aggarwal C, Langer CJ. : Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Current Opinion in Oncology 24(2): 130-6. March 2012.
Mehra R, Aggarwal C, Cohen RB: Management of Thyroid and Parathyroid Cancers. Head and Neck Cancer: Multimodality Management. Bernier, Jacques (eds.). FEB 2011 Notes: ISBN: 978-1-60327-934-5.
Aggarwal C, Somaiah N, Simon GR: Biomarkers with Predictive and Prognostic Function in Non-Small Cell Lung Cancer: Ready for Prime Time? Journal of the National Comprehensive Cancer Network 8(7): 822-832, JUL 2010.
Aggarwal C, Egleston B, Li L, George S : Role of surgery in the management of Stage IIIA Non Small Cell Lung Cancer-The Fox Chase Cancer Center Experience. Journal Of Clinical Oncology/Annual Meeting of American Society of Clinical Oncology 28: 15s, JUN 2010 Notes: Abstract 7066.
Aggarwal C and Borghaei H: Rational use of cetuximab in the treatment of advanced non-small cell lung cancer. Oncotargets And Therapy 2: 251-260, AUG 2009.
Cohen RB, Jones SF, Aggarwal C, Von Mehren M, Cheng J, Spigel DR, Greco FA, Mariani M, Rocchetti M, Ceruti R, Comis S, Laffranchi B, Moll J, Burris HA: A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors. Clinical Cancer Research 15(21): 6694-6701, NOV 2009.
Scott WJ, Aggarwal C, Lebenthal A, Egleston B, Borghaei H, Mehra R, Somaiah N, Turaka A, Simon GR : Influence of surgical interventions on survival in patients with stage IIIb non-small cell lung cancer: The Fox Chase Cancer Center experience. Journal of Clinical Oncology/Annual Meeting of American Society of Clinical Oncology 28: 15s, JUN 2010 Notes: Abstract 7067.
